Targeting the Gut to Improve Seizure Control in CDKL5 Deficiency Disorder (CDD)
Clinical trial NCT06448663 · UNKNOWN
Trial details
- NCT number
- NCT06448663
- Sponsor
- University of Milan
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2025-01-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.